Comparison of Fluticasone Furoate Nasal Spray Versus Combined Oral Anti-Histamine and Anti-Leukotriene Therapy in Allergic Rhinitis

Comparison of Fluticasone Furoate Nasal Spray Versus Combined Oral Anti-Histamine and Anti-Leukotriene Therapy in Allergic Rhinitis

Background:.To compare intranasal Fluticasone furoate spray with oral anti-histamine and anti-leukotriene therapy in allergic rhinitis in terms of change in mean nasal symptoms score. Methods: In this randomized control trial two groups were selected having 40 patients in each group. To group (A) ce...

Full description

Bibliographic Details
Main Authors:	Junaid Shahzad, Sadia Chaudhry, Mohammad Moaz Aslam, Amir Akbar, Maidah Hanif
Format:	Article
Language:	English
Published:	Rawalpindi Medical University 2018-06-01
Series:	Journal of Rawalpindi Medical College
Subjects:	Fluticasone Furoate Cetirizine Montelukast Allergic Rhinitis
Online Access:	https://www.journalrmc.com/index.php/JRMC/article/view/888

Similar Items

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
by: Maria Doulaptsi, et al.
Published: (2021-09-01)

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
by: Philip Lance A. Liu, et al.
Published: (2010-06-01)

Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
by: Nandish Chennakeshavaraju, et al.
Published: (2020-01-01)

Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
by: Kumar RS, et al.
Published: (2022-06-01)

Efficacy and Safety of Fluticasone Furoate Nasal Spray in Japanese Children with Perennial Allergic Rhinitis: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
by: Kimihiro Okubo, et al.
Published: (2014-01-01)

A comparative study of fluticasone propionate, mometasone furoate, and saline nasal spray in the treatment of children with adenoid hypertrophy}
by: Gurbax Singh, et al.
Published: (2023-01-01)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
by: Covelli H, et al.
Published: (2015-12-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Fixed combination of vilanterol triphenatate/fluticasone furoate in the treatment of patients with bronchial asthma and chronic obstructive pulmonary disease: a literature review
by: A. A. Viesel, et al.
Published: (2022-01-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
by: Murat Yarıktaş, et al.
Published: (2002-12-01)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
by: Peter R. Bremner, et al.
Published: (2018-01-01)

Comparison of Mometasone Furoate Monohydrate (Nasonex) and Fluticasone Propionate (Flixonase) Nasal Sprays in the Treatment of Dust Mite-sensitive Children with Perennial Allergic Rhinitis
by: Ka-Kit Mak, et al.
Published: (2013-08-01)

A Comparative Study of Fluticasone Alone and Fluticasone with Azelastine Nasal Spray in Patients with Allergic Rhinitis
by: Fidelis G. Dass A, et al.
Published: (2021-12-01)

Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma
by: Akira Umeda, et al.
Published: (2019-01-01)

Efficacy of intranasal fluticasone propionate nano nasal spray in management of chronic rhinitis: a randomized clinical trial
by: Yasir Mehmood, et al.
Published: (2023-01-01)

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma
by: Philippe Bareille, et al.
Published: (2020-02-01)

Mometasone furoate in the treatment of allergic rhinitis: a complex therapeutic effect
by: R. S. Fassakhov, et al.
Published: (2021-09-01)

Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan
by: Akira Umeda, et al.
Published: (2023-04-01)

Effect of intranasal mometasone furoate administered in children with coexisting allergic rhinitis and asthma towards asthma attacks and lung function
by: Ellen P. Gandaputra, et al.
Published: (2009-12-01)

Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study
by: Daniel Dedman, et al.
Published: (2019-04-01)

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS
by: Vallejo-Aparicio LA, et al.
Published: (2018-09-01)

Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA)
by: Martti Anton Antila, et al.

An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis
by: Zhengbo Wei, et al.
Published: (2023-12-01)

Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial
by: Peter Daley-Yates, et al.
Published: (2022-09-01)

The Effects of Topical Mometasone Furoate Nasal Spray Therapy on Allergic Rhinitis Symptoms, IL-4, and IL-8 Levels
by: Sema Başak, et al.
Published: (2003-06-01)

Comparison of Loratadine and Cetirizine in Perennial Allergic Rhinitis
by: Ali Eftekharian, et al.
Published: (2015-07-01)

Compare of the effect of doxepin and citerizine in treatment of allergic rhinitis
by: Zamani Barsari F, et al.
Published: (2015-04-01)

DRUG-INDUCED RHINITIS: QUESTIONS AND ANSWERS
by: V. V. Shelenkova
Published: (2017-05-01)

Anti-leukotriene agents in modern therapy of bronchial asthma in children
by: Yu. L. Mizernitskiy
Published: (2020-03-01)

Montelukast As An Add On Therapy In Asthma As Compared To Its Use In Asthma Associated With Concomitant Rhinitis Symptoms
by: kassim M. Sultan
Published: (2011-07-01)

Effect of Combination Montelukast and Nasal Mometasone on Childhood Adenoid Hypertrophy
by: Mohsen Jafari, et al.
Published: (2024-03-01)

Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
by: Angela Rizzi, et al.
Published: (2022-07-01)

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
by: Sethi S, et al.
Published: (2023-04-01)

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis
by: Bing Zhou, et al.
Published: (2023-08-01)

Place of topical corticosteroids in therapy of allergic rhinitis
by: S. V. Ryazantsev, et al.
Published: (2018-04-01)

A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis
by: Mozhgan Moghtaderi, et al.
Published: (2023-04-01)

The effect of treatment with fexofenadine and fluticasone propionate on the gene expression levels of Th9 transcription factors in patients with allergic rhinitis
by: Ali asghar Askari, et al.
Published: (2021-12-01)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
by: Roberto W. Dal Negro, et al.
Published: (2018-06-01)

Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis
by: Erkan Yildiz, et al.
Published: (2019-12-01)